CORRECTION article

Front. Pharmacol., 17 May 2024

Sec. Experimental Pharmacology and Drug Discovery

Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1392148

Corrigendum: NmFGF1-regulated glucolipid metabolism and angiogenesis improves functional recovery in a mouse model of diabetic stroke and acts via the AMPK signaling pathway

  • 1. The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

  • 2. School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China

  • 3. Research Units of Clinical Translation of Cell Growth Factors and Diseases Research, Chinese Academy of Medical Science, Wenzhou, China

In the published article, there was an error in Figure 4 and Figure 5 as published. The representative images and quantified data in Figures 4B, C and Figures 5G, H have been presented incorrectly. Two pictures were taken from the same cell culture well with HG treatment in Figure 4B and HG + OGD + nmFGF1+A-769662 treatment in Figure 5G, respectively. Therefore, we reassembled and quantified all pictures in Figures 4B, C and Figures 5G, H. The corrected Figure 4 and Figure 5 and its captions appear below.

FIGURE 4

FIGURE 5

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

ischemic stroke, diabetes, nmFGF1, angiogenesis, AMPK

Citation

Zhao Y, Ye S, Lin J, Liang F, Chen J, Hu J, Chen K, Fang Y, Chen X, Xiong Y, Lin L and Tan X (2024) Corrigendum: NmFGF1-regulated glucolipid metabolism and angiogenesis improves functional recovery in a mouse model of diabetic stroke and acts via the AMPK signaling pathway. Front. Pharmacol. 15:1392148. doi: 10.3389/fphar.2024.1392148

Received

14 March 2024

Accepted

03 May 2024

Published

17 May 2024

Volume

15 - 2024

Edited and reviewed by

Yidong Wang, Xi’an Jiaotong University, China

Updates

Copyright

*Correspondence: Xianxi Tan, ; Li Lin, ; Ye Xiong,

† These authors have contributed equally to this work and share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics